Radiation Effects and Mitigation Strategies

Ionising radiation plays a pivotal role in medicine, industry and research, yet it poses significant risks to living systems. At the molecular level, exposure induces DNA double-strand breaks, base modifications and cross-links, triggering cell-cycle arrest, apoptosis or mutagenesis. Reactive oxygen and nitrogen species generated by radiolysis of water amplify damage and initiate inflammatory and fibrotic responses in normal tissues. Clinically, these processes underpin acute syndromes—such as hematopoietic failure and gastrointestinal collapse—and long-term consequences including carcinogenesis, organ fibrosis and neurocognitive deficits. Strategies to mitigate these effects span physical measures (shielding, dose fractionation, advanced imaging protocols), biological countermeasures (antioxidants, epigenetic modulators, growth factors), molecular biomarkers for rapid biodosimetry and cellular therapies (stem-cell and stromal-cell transplantation). Recent advances have elucidated the interplay between redox signalling, epigenetic regulation and immune modulation, guiding the design of next-generation radioprotectors and radiomitigators. The development of sensitive in vivo biomarkers has improved dose assessment following diagnostic or accidental exposures, while novel pharmacological agents and nutritional approaches offer the prospect of targeted protection without compromising therapeutic efficacy. This integrative framework supports global efforts in radiotherapy optimisation, disaster preparedness and exploration missions challenged by cosmic radiation.

Research from Nature Portfolio

Recent studies have demonstrated that a naturally derived compound can significantly reduce radiation-induced enteritis by preserving intestinal crypt architecture, enhancing Lgr5+ stem-cell survival and attenuating markers of DNA damage and apoptosis. This work underscores the potential of phytochemicals to modulate p53 signalling and γH2AX activation in gastrointestinal tissues. In parallel, foundational investigations into blood-based gene expression have identified a transcriptional biomarker whose levels rise proportionally with ionising radiation dose. This marker enables accurate in vivo dose estimation across diagnostic and therapeutic ranges, maintaining reliability even at low exposures and under varying patient conditions, thereby providing a robust tool for rapid biological dosimetry.

Radiation Effects and Mitigation Strategies publication trend

The graph below shows the total number of articles in radiation effects and mitigation strategies across all publications each year (not limited to Nature Index journals).

Technical terms

Ionising radiation: Electromagnetic waves or particles with sufficient energy to ionise atoms and molecules in biological tissues.

Radioprotector: An agent administered prior to radiation exposure to prevent or reduce cellular and molecular damage.

Radiomitigator: A compound given after radiation exposure but before symptom onset, aimed at minimising toxicity and promoting recovery.

Reactive oxygen species (ROS): Highly reactive molecules derived from oxygen that inflict oxidative damage on DNA, proteins and lipids.

Biodosimetry: The quantitative measurement of biological responses to determine absorbed radiation dose.

References

1. Effects of Thymoquinone on radiation enteritis in mice. Scientific Reports (2018).
2. Radiation‐Induced Normal Tissue Damage: Oxidative Stress and Epigenetic Mechanisms. Oxidative Medicine and Cellular Longevity (2019).
3. FDXR is a biomarker of radiation exposure in vivo. Scientific Reports (2018).
4. Radioprotection and Radiomitigation: From the Bench to Clinical Practice. Biomedicines (2020).